Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
题目
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study
作者
Constance Thibault, Mostefa Bennamoun, Aude Fléchon, Gwenaelle Gravis, Damien Pouessel, Pierre Combe, Delphine Borchiellini, Yohann Loriot, Brigitte Laguerre, Philippe Barthélémy, Olivier Huillard, Marine Gross-Goupil, Audrey Le Roy, Loic Jaffrelot, Mathilde Cancel, François Audenet, Houda Belhouari, Ghalia Kaci, Eve Lepicard, Dewi Vernerey, Julie Henriques, Stéphane Oudard
Scihuhuan